120 related articles for article (PubMed ID: 9290216)
21. A two stage conditional power adaptive design adjusting for treatment by covariate interaction.
Ayanlowo AO; Redden DT
Contemp Clin Trials; 2008 May; 29(3):428-38. PubMed ID: 18053774
[TBL] [Abstract][Full Text] [Related]
22. Estimation of a parameter and its exact confidence interval following sequential sample size reestimation trials.
Cheng Y; Shen Y
Biometrics; 2004 Dec; 60(4):910-8. PubMed ID: 15606411
[TBL] [Abstract][Full Text] [Related]
23. Mantel-Haenszel test statistics for correlated binary data.
Zhang J; Boos DD
Biometrics; 1997 Dec; 53(4):1185-98. PubMed ID: 9423245
[TBL] [Abstract][Full Text] [Related]
24. Group sequential design for comparative diagnostic accuracy studies.
Mazumdar M; Liu A
Stat Med; 2003 Mar; 22(5):727-39. PubMed ID: 12587102
[TBL] [Abstract][Full Text] [Related]
25. A general statistical principle for changing a design any time during the course of a trial.
Müller HH; Schäfer H
Stat Med; 2004 Aug; 23(16):2497-508. PubMed ID: 15287080
[TBL] [Abstract][Full Text] [Related]
26. A general formulation for a one-sided group sequential design.
Moser BK; George SL
Clin Trials; 2005; 2(6):519-28. PubMed ID: 16422312
[TBL] [Abstract][Full Text] [Related]
27. Adaptive designs based on the truncated product method.
Neuhäuser M; Bretz F
BMC Med Res Methodol; 2005 Sep; 5():30. PubMed ID: 16171518
[TBL] [Abstract][Full Text] [Related]
28. Comparison of four sequential methods allowing for early stopping of comparative clinical trials.
Sebille V; Bellissant E
Clin Sci (Lond); 2000 May; 98(5):569-78. PubMed ID: 10781388
[TBL] [Abstract][Full Text] [Related]
29. Sample size and the probability of a successful trial.
Chuang-Stein C
Pharm Stat; 2006; 5(4):305-9. PubMed ID: 17128428
[TBL] [Abstract][Full Text] [Related]
30. Use of two-stage test statistic in the two-period crossover trials.
Wang SJ; Hung HM
Biometrics; 1997 Sep; 53(3):1081-91. PubMed ID: 9333341
[TBL] [Abstract][Full Text] [Related]
31. Assessment of futility in clinical trials.
Snapinn S; Chen MG; Jiang Q; Koutsoukos T
Pharm Stat; 2006; 5(4):273-81. PubMed ID: 17128426
[TBL] [Abstract][Full Text] [Related]
32. Tests of non-null hypothesis on proportions for stratified data.
Zhao G
Stat Med; 2008 Apr; 27(9):1429-46. PubMed ID: 17668916
[TBL] [Abstract][Full Text] [Related]
33. Approaches for optimal sequential decision analysis in clinical trials.
Carlin BP; Kadane JB; Gelfand AE
Biometrics; 1998 Sep; 54(3):964-75. PubMed ID: 9750245
[TBL] [Abstract][Full Text] [Related]
34. Stochastically curtailed phase II clinical trials.
Ayanlowo AO; Redden DT
Stat Med; 2007 Mar; 26(7):1462-72. PubMed ID: 16900560
[TBL] [Abstract][Full Text] [Related]
35. Efficient group sequential designs when there are several effect sizes under consideration.
Jennison C; Turnbull BW
Stat Med; 2006 Mar; 25(6):917-32. PubMed ID: 16220524
[TBL] [Abstract][Full Text] [Related]
36. Practical usage of O'Brien's OLS and GLS statistics in clinical trials.
Dallow NS; Leonov SL; Roger JH
Pharm Stat; 2008; 7(1):53-68. PubMed ID: 17390306
[TBL] [Abstract][Full Text] [Related]
37. Group sequential test strategies for superiority and non-inferiority hypotheses in active controlled clinical trials.
Wang SJ; Hung HM; Tsong Y; Cui L
Stat Med; 2001 Jul; 20(13):1903-12. PubMed ID: 11427948
[TBL] [Abstract][Full Text] [Related]
38. Reducing sample sizes in genome scans: group sequential study designs with futility stops.
König IR; Schäfer H; Ziegler A; Müller HH
Genet Epidemiol; 2003 Dec; 25(4):339-49. PubMed ID: 14639703
[TBL] [Abstract][Full Text] [Related]
39. Sequential monitoring of randomization tests: stratified randomization.
Zhang Y; Rosenberger WF; Smythe RT
Biometrics; 2007 Sep; 63(3):865-72. PubMed ID: 17825016
[TBL] [Abstract][Full Text] [Related]
40. Conditional analysis of mixed Poisson processes with baseline counts: implications for trial design and analysis.
Cook RJ; Wei W
Biostatistics; 2003 Jul; 4(3):479-94. PubMed ID: 12925513
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
